Companies / Exagen
Exagen
United States
Exagen provides physicians with advanced testing for accurate and timely diagnosis, prognosis and monitoring of autoimmune conditions.
Exagen, based in United States, has 4 investors on file, among them Cottonwood Technology Fund, EPIC Ventures and Mesa Verde Venture Partners. Its site was last checked 13 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by EXAGEN INC. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
2 headlines naming ExagenEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Exagen and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Cottonwood Technology Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/exagen.com/investors
# also
GET /v1/companies/exagen.com
GET /v1/companies/exagen.com/news